Research ArticleArticle
Suboptimal Immunization Coverage among Canadian Rheumatology Patients in Routine Clinical Care
Tedi Qendro, María Laura de la Torre, Pantelis Panopalis, Elizabeth Hazel, Brian J. Ward, Inés Colmegna and Marie Hudson
The Journal of Rheumatology July 2019, jrheum.181376; DOI: https://doi.org/10.3899/jrheum.181376
Tedi Qendro
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
María Laura de la Torre
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
Pantelis Panopalis
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
Elizabeth Hazel
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
Brian J. Ward
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
Inés Colmegna
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
Marie Hudson
From the Department of Medicine, McGill University, Montreal; Division of Rheumatology, McGill University Health Center, Montreal; Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center, Montreal; Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital, Montreal, Canada; Internal Medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno, Buenos Aires, Argentina. This research was in part supported by the Canadian Rheumatology Association and a 2016 Canadian Institute for Outcomes in Rheumatology Care grant on “Strategies to enhance influenza/pneumococcal vaccination coverage among rheumatoid arthritis patients”. T. Qendro, MSc, Department of Medicine, McGill University; M.L. de la Torre, MD, Internal medicine, Rheumatology and Immunology, Centro de Educacion Medica e Investigaciones Clinicas Norberto Quirno; P. Panopalis, MD, Division of Rheumatology, McGill University Health Center; E. Hazel, MD, Division of Rheumatology, McGill University Health Center; B.J. Ward, MD, DTM&H, Infectious Diseases and Immunity in Global Health Program, Research Institute of the McGill University Health Center; I. Colmegna, MD, Division of Rheumatology, McGill University Health Center; M. Hudson, MD, MPH, FRCPC, Division of Rheumatology and Lady Davis Institute for Medical Research, Jewish General Hospital. Address correspondence to Dr. M. Hudson, Jewish General Hospital and Lady David Research Institute, 3755 Côte Ste-Catherine Road, Room A725, Montreal, Quebec H3T 1E2, Canada. E-mail: marie.hudson@mcgill.ca. Accepted for publication June 25, 2019.
Data supplements
Data Supplement
In this issue
The Journal of Rheumatology
Vol. 51, Issue 3
1 Mar 2024
Suboptimal Immunization Coverage among Canadian Rheumatology Patients in Routine Clinical Care
Tedi Qendro, María Laura de la Torre, Pantelis Panopalis, Elizabeth Hazel, Brian J. Ward, Inés Colmegna, Marie Hudson
The Journal of Rheumatology Jul 2019, jrheum.181376; DOI: 10.3899/jrheum.181376